Clinical trial
Olanzapine in the Treatment of Hair Pulling (Trichotillomania)
NCT00182507 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00182507 |
|---|---|
| Title | Olanzapine in the Treatment of Hair Pulling (Trichotillomania) |
| Official title | A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Trichotillomania |
| Intervention type | Drug |
| Interventions | Olanzapine |
| Enrollment | 34 |
| Start date | Jun 1, 2000 |
| Completion | Mar 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 11, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: